CLU and neoplasm: The expression levels of PROS1 (P = .001), CLU (P < .001), and LRG1 (P = .002) were significantly lower in PTC patients with large tumor size (>2 cm) than in small tumor size patients (≤2 cm), respectively (Tables 4–6).